Search results
Results from the WOW.Com Content Network
Vasculitis [3] Alpidem (Ananxyl) 1995. Worldwide. Not approved in the US, withdrawn in France in 1994 [4] and the rest of the market in 1995 because of rare but serious hepatotoxicity. [3][5] Alosetron (Lotronex) 2000. US. Serious gastrointestinal adverse events; ischemic colitis; severe constipation. [2]
Betahistine. Betahistine, sold under the brand name Serc among others, is an anti-vertigo medication. It is commonly prescribed for balance disorders or to alleviate vertigo symptoms. It was first registered in Europe in 1970 for the treatment of Ménière's disease, but current evidence does not support its efficacy in treating it. [4][5]
e. Benzodiazepine withdrawal syndrome (BZD withdrawal) is the cluster of signs and symptoms that may emerge when a person who has been taking benzodiazepines as prescribed develops a physical dependence on them and then reduces the dose or stops taking them without a safe taper schedule.
This year’s recall involves over 300 products and 23 states. Earlier in 2022, a rodent infestation at a Family Dollar distribution facility caused a recall of over-the-counter drugs, dietary ...
Recall information. FDA develops a strategy for each individual recall that sets forth how extensively it will check on a company's performance in recalling the product in question. For a Class I recall, for example, FDA would check to make sure that each defective product has been recalled or reconditioned. In contrast, for a Class III recall ...
Here’s a list of some of the beverages recalled so far this year: Schweppes Zero Sugar Gingerale. PepsiCo’s Mug Root Beer. Martinelli’s Apple Juice. Natural Waters of Viti Limited’s Fiji ...
Vitafusion melatonin and Multivites vitamins are part of a recall, the brand's parent company, Church & Dwight, said in an FDA recall notice.
Benfotiamine. Benfotiamine (rINN, or S-benzoylthiamine O-monophosphate) is a synthetic, fat-soluble, S -acyl derivative of thiamine (vitamin B1) that is approved in some countries as a medication or dietary supplement to treat diabetic sensorimotor polyneuropathy. Benfotiamine was developed in late 1950s in Japan. [1][2]